Huda Y Zoghbi Regeneron Pharmaceuticals, Inc. (REGN) insider trading activity

Huda Y Zoghbi is Director of REGENERON PHARMACEUTICALS, INC.. Currently has a direct ownership of 1,247 shares of REGN, which is worth approximately $891,767. The most recent transaction as insider was on Jan 02, 2024, when has been sold 1,117 shares (Common Stock) at a price of $900.0 per share, resulting in proceeds of $1,005,300. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.25K

0% 3M change

0% 12M change

Total Value Held $891,767

Huda Y Zoghbi Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 02 2024	SELL Open market or private sale	$1,005,300 $900.0 p/Share	1,117 Reduced 47.25%	1,247 Common Stock
Jan 02 2024	BUY Grant, award, or other acquisition	-	135 Added 8.9%	1,382 Common Stock
Jan 02 2024	BUY Exercise of conversion of derivative security	$437,774 $391.92 p/Share	1,117 Added 32.09%	2,364 Common Stock
Oct 13 2023	SELL Open market or private sale	$850,000 $850.0 p/Share	1,000 Reduced 44.5%	1,247 Common Stock
Oct 13 2023	BUY Exercise of conversion of derivative security	$391,920 $391.92 p/Share	1,000 Added 30.8%	2,247 Common Stock
Jan 03 2023	BUY Grant, award, or other acquisition	-	165 Added 11.69%	1,247 Common Stock
Mar 16 2022	SELL Open market or private sale	$1,350,000 $675.0 p/Share	2,000 Reduced 64.89%	1,082 Common Stock
Mar 16 2022	BUY Exercise of conversion of derivative security	$783,840 $391.92 p/Share	2,000 Added 39.35%	3,082 Common Stock
Jan 03 2022	BUY Grant, award, or other acquisition	-	191 Added 15.0%	1,082 Common Stock
Sep 14 2021	SELL Open market or private sale	$648,700 $650.0 p/Share	998 Reduced 52.83%	891 Common Stock
Sep 14 2021	BUY Exercise of conversion of derivative security	$391,136 $391.92 p/Share	998 Added 34.57%	1,889 Common Stock
Sep 13 2021	SELL Open market or private sale	$1,302 $651.1 p/Share	2 Reduced 0.22%	891 Common Stock
Sep 13 2021	BUY Exercise of conversion of derivative security	$784 $391.92 p/Share	2 Added 0.22%	893 Common Stock
Jan 04 2021	BUY Grant, award, or other acquisition	-	248 Added 21.77%	891 Common Stock

HYZ

Huda Y Zoghbi

Director

Tarrytown, NY

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells REGN shares.

Notify only if

Value

Insider Trading

Get notified when an Regeneron Pharmaceuticals, Inc. insider buys or sells REGN shares.

Notify only if

Operation

Value

Type

News

Receive news related to REGENERON PHARMACEUTICALS, INC.

Track Activities on REGN

Account